Philips
About: Koninklijke Philips is a diversified global healthcare company operating in three segments: diagnosis and treatment, connected care, and personal health. Nearly 50% of the company's revenue comes from the diagnosis and treatment segment, which features imaging systems, ultrasound equipment, and image-guided therapy solutions. The connected care segment (under 30% of revenue) encompasses monitoring and analytics systems for hospitals, informatics business, and also houses the sleep and respiratory care segment. Personal health business (remainder of revenue) is mainly oral health and personal care product lines, which include electric toothbrushes and men's grooming and personal-care products.
Employees: 67,823
0
Funds holding %
of 7,323 funds
–
Analysts bullish %
Fund manager confidence
Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)
20% more first-time investments, than exits
New positions opened: 36 | Existing positions closed: 30
9% more repeat investments, than reductions
Existing positions increased: 104 | Existing positions reduced: 95
2% more capital invested
Capital invested by funds: $1.45B [Q4 2024] → $1.48B (+$26.6M) [Q1 2025]
0.16% more ownership
Funds ownership: 6.02% [Q4 2024] → 6.18% (+0.16%) [Q1 2025]
0% more funds holding in top 10
Funds holding in top 10: 1 [Q4 2024] → 1 (+0) [Q1 2025]
9% less call options, than puts
Call options by funds: $19.9M | Put options by funds: $21.8M
1% less funds holding
Funds holding: 312 [Q4 2024] → 308 (-4) [Q1 2025]
Research analyst outlook
We haven’t received any recent analyst ratings for PHG.
Financial journalist opinion
Based on 14 articles about PHG published over the past 30 days
Negative
Zacks Investment Research
6 hours ago
Philips Q2 Earnings and Revenues Decline Year Over Year, Shares Fall
PHG's second-quarter 2025 earnings and revenues decline year over year, with macro headwinds and tariffs weighing on the stock.
Positive
Barrons
1 day ago
Trade Latest: China Talks in Focus, Europe's Philips Gets a Boost.
For any countries that have yet to agree a deal, new tariff rates are due to come into effect on Friday, Aug. 1—though such deadlines have proved to be flexible in the past.
Neutral
Seeking Alpha
1 day ago
Koninklijke Philips N.V. (PHG) Q2 2025 Earnings Call Transcript
Koninklijke Philips N.V. (NYSE:PHG ) Q2 2025 Earnings Conference Call July 29, 2025 3:00 AM ET Company Participants Charlotte Hanneman - Executive VP, CFO & Member of Board of Management Durga Doraisamy - Corporate Participant Roy Jakobs - President, CEO & Chairman of the Board of Management Conference Call Participants David James Adlington - JPMorgan Chase & Co, Research Division Edward Nicholas Ridley-Day - Redburn (Europe) Limited, Research Division Graham Doyle - UBS Investment Bank, Research Division Hassan Al-Wakeel - Barclays Bank PLC, Research Division Hugo Solvet - BNP Paribas Exane, Research Division Julien Dormois - Jefferies LLC, Research Division Richard Felton - Goldman Sachs Group, Inc., Research Division Veronika Dubajova - Citigroup Inc., Research Division Operator Welcome to the Philips' Second Quarter and Semiannual 2025 Results Conference Call on Tuesday, July 29, 2025.
Positive
Market Watch
1 day ago
Philips lifts profit outlook on tariff mitigation as Stellantis flags $1.7 billion hit from levies
Shares of health device maker Phillips rallied as much as 14% on Tuesday as the company lifted its earnings guidance despite a hefty hit from tariffs.
Neutral
GlobeNewsWire
1 day ago
Indonesia's Ministry of Health and Philips to deliver nationwide coverage of advanced image-guided therapy systems in Indonesia, expanding access to cardiac, stroke and cancer care in all 38 provinces
July 29, 2025 Long-term multiyear agreements will see Philips installing its advanced Azurion image-guided therapy systems nationwide across all provinces, including rural and remote areas Initiative brings minimally invasive care to millions of cardiac, stroke and cancer patients in Indonesia Combines cutting-edge treatment technology, services and training to strengthen Indonesia's health infrastructure Amsterdam, the Netherlands and Jakarta, Indonesia – In a major step toward transforming healthcare delivery, Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology and the Indonesia's Ministry of Health today announced plans to deploy state-of-the-art image-guided therapy systems nationwide, as part of their signed agreements, under the Strengthening Indonesia's Healthcare Referral Network (SIHREN) project. The landmark agreements, recently awarded to Philips after an international, competitive bidding process, combine cutting-edge treatment technology, services and training to strengthen Indonesia's health infrastructure.
Negative
Reuters
1 day ago
Philips' sees tariffs impact of 150-200 million euros after US-EU deal
Dutch healthcare technology company Philips said it expects an impact of 150-200 million euros ($173-232 million) from import tariffs after the U.S. and the European Union agreedto the United States imposing a 15% rate on most EU goods.
Neutral
GlobeNewsWire
1 day ago
Philips builds strong order intake momentum and drives margin expansion in Q2
July 29, 2025 Q2 2025 Group Highlights Comparable order intake growth 6% Group sales EUR 4.3 billion, reflecting 1% increase in comparable sales Income from operations EUR 400 million Adjusted EBITA margin increased 130 bps to 12.4% of sales Free cash flow increased to EUR 230 million Philips increases full year 2025 outlook for Adjusted EBITA margin and free cash flow; reiterates comparable sales growth outlook Roy Jakobs, CEO of Royal Philips: “We are focused on driving profitable growth and delivering better care for more people. We built order intake growth momentum, supported by our recently launched AI-powered innovations.
Neutral
GlobeNewsWire
6 days ago
Philips announces collaboration with Epic to enhance ambulatory cardiac monitoring
July 24, 2025 Philips will now offer the largest cardiac care portfolio through Epic's Aura platform CAMBRIDGE, Mass. – Royal Philips (NYSE: PHG, AEX: PHIA) a global leader in health technology, today announced a collaboration with Epic to integrate Philips' suite of cardiac ambulatory monitoring and diagnostics services with Aura, the specialty diagnostics suite of the leading electronic health record (EHR) company.
Positive
Zacks Investment Research
1 week ago
Here's Why Royal Philips (PHG) is a Strong Value Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Neutral
GlobeNewsWire
1 week ago
Philips advances minimally invasive therapy procedures in prostate cancer care with FDA 510(k) clearance for image-guided navigation technology
July 23, 2025 Supporting prostate cancer diagnosis with more precise guidance for clinicians, offering better patient care Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced a major advancement in image-guided navigation for prostate cancer care with the FDA 510(k) clearance of the latest Philips UroNav version. The system includes a new advanced annotation [1] workflow that supports clinicians during focal therapy procedures, helping deliver more precise, minimally invasive care.
Charts implemented using Lightweight Charts™